✦ LIBER ✦

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors

✍ Scribed by Stephen Ansell,Donald Northfelt,Ian Flinn…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of an agonist anti-CD27

✍ Howard Burris,Stephen Ansell,John Neumanitis… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 65 KB

A phase I study of the human monoclonal

✍ Weekes, Colin D.; Beeram, Muralidhar; Tolcher, Anthony W.; Papadopoulos, Kyriako 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 387 KB

367 A first-in-human Phase 1 study of an

✍ L. Rosen; M.S. Gordon; H.I. Hurwitz; M.K. Wong; J. Goldman; B.J. Adams; D. Alvar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A phase I study of olaratumab, an anti-p

✍ Chiorean, E. Gabriela; Sweeney, Christopher; Youssoufian, Hagop; Qin, Amy; Donta 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 529 KB

30 A phase I clinical trial of HGS-ETR1,

✍ R.B. Cohen; N.J. Meropol; K.M. Padavic; N.L. Fox; A. Corey; M. Fleming; M. Mita; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 136 KB

372 A phase I dose-escalation study of t

✍ C. Weekes; P. Hedge; Y. Xin; R. Yu; H. Xiang; L. Gore; M. Beeram; R. Brachmann; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB